1st world conference on access to medical products and ... wednesday, 22nd november, 2017:programme...

1

1st World Conference on Access to Medical

Products and International Laws for Trade and

Health in the Context of the 2030 Agenda for

Sustainable Development

21-23 November 2017,

The Taj Mahal Hotel

New Delhi, India

2

Tuesday 21st November, 2017

Access to Medical Products: Achieving SDG 2030 Goals

21 November, 2017-Tuesday, 08:00-09:00: Registration

21 November 2017- Thursday, 09:00-10:30: Inaugural Session

21 November, 2017-Tuesday, 10:30-10:45: Tea Break

21 November, 2017-Tuesday, 10:45-12:30: Plenary Session 1: UN

High Level Panel on Access to Medicines in the context of SDGs

Time Plenary Session 1- Tuesday, 21 November 2017 Room

Tuesday,

10:45-

12:30

UN High Level Panel on Access to Medicines in the context

of SDGs

Chairs: Dr VK Paul, Member, NITI Aayog, Government of India

Ms Preeti Sudan, Secretary, Health, Ministry of Health and Family

Welfare, Government of India

Dr Soumya Swaminathan, Secretary, Department of Health and

Research & Director General, Indian Council of Medical

Research, Government of India

A

Lead Discussants

1. Ambassador Dr Virander Paul, Deputy Permanent

Representative of India to the United Nations

2. Ms Ruth Dreifuss, Co-chair, UN High Level Panel on Access to

Medicines; Former President, Swiss Confederation, Geneva

3. Dr Jorge Bermudez, Senior Researcher in Public Health,

National School of Public Health, Fiocruz, Ministry of Health,

Brazil

4. Dr Mandeep Dhaliwal, Director-HIV, Health and

Development Group, United Nations Development Program,

USA

3

Panelists (Members and Expert Advisory Group, UN High Level

Panel on Access to Medicines, and WHO)

1. Dr Peter Beyer, Senior Advisor, Department Of Essential

Medicines and Health Products, World Health Organization,

Geneva

2. Ms Maria Lorena Di Giano, Executive Director, Fundacio

Grupo Efecto Positivo and General Coordinator of RedLam,

Argentina

3. Professor Anthony D So, Professor of the Practice and

Director, IDEA (Innovation+Design Enabling Access) Initiative,

Department of International Health, Johns Hopkins

Bloomberg School of Public Health, Baltimore, Maryland,

USA

4. Dr Mohga Kamal Yanni, Senior Health and HIV Policy Adviser,

Oxfam GB, UK

5. Mr Anand Grover, Former UN Special Rapporteur and

Member- Expert Advisory Group, UN High Level Panel on

Access to Medicines, India

21 November, 2017-Tuesday, 12:30-13:30: Lunch

21 November, 2017-Tuesday, 13:30-15:30: Parallel Session 1-

Regulatory Pathways For Safe, Quality, Efficacious And Affordable

Medical Products Including In Emergencies To Achieve SDG Goals

Time Parallel Session 1 - Tuesday, 21 November 2017 Room

Tuesday,

13:30-

15:30

Regulatory Pathways For Safe, Quality, Efficacious And

Affordable Medical Products Including In Emergencies To

Achieve SDG Goals

Chair: Dr RK Vats, Additional Secretary, Ministry of Health and

Family Welfare, GOI

Co-chair: Dr Renu Swarup, Senior Adviser, Department of

Biotechnology and Managing Director, Biotechnology Industry

Research Assistance Council- Biopharma Mission, India

A

4

Lead Discussants

1. Dr Gagandeep Kang, Executive Director, Translational Health

Science and Technology, India

2. Dr GN Singh, Drugs Controller General (India), Central Drugs

Standard Control Organization, India

3. Dr Stephen B Kennedy, Coordinator for EVD Research,

Incident Management System, Ministry of Health, Liberia

Panelists

1. Dr Anban Pillay, Director, National Department of Health,

South Africa

2. Dr Anil Koul, Director, CSIR-Institute of Microbial Technology,

India

3. Dr Jorge Bermudez, Senior Researcher in Public Health,

National School of Public Health, Fiocruz, Ministry of Health,

Brazil

4. Ms Leena Menghaney, Head- South Asia, Access Campaign,

Medecins Sans Frontieres, India

5. Dr Taslimarif Saiyed, CEO & Director, Centre for Cellular and

Molecular Platforms, Department of Biotechnology, India

21 November, 2017-Tuesday, 13:30-15:30: Parallel Session 2:

Affordability and Fair Pricing of Medical Products

Time Parallel Session 2- Tuesday, 21 November 2017 Room

Tuesday,

13:30-

15:30

Affordability and Fair Pricing of Medical Products

Chair: Mr Jai Priye Prakash, Secretary, Department of

Pharmaceuticals, Ministry of Chemicals and Fertilizers,

Government of India

Co-chair: Dr Henk Bekedam, WHO Representative to India; Mr

Bhupendra Singh, Chairman, National Pharmaceutical Pricing

Authority, Government of India

B

Lead Discussants

1. Professor Fatima Suleman, Discipline of Pharmaceutical

5

Sciences, University of Kwazulu-Natal, South Africa

2. Dr Sham Mailankody, Memorial Sloan Kettering Cancer

institute, USA

3. Dr Andrew Rintoul, Scientist, Pricing & Health Technology

Assessment, World Health Organization, Geneva

Panelists

1. Ms Michelle Childs, Head of Policy and Advocacy, Drugs

for Neglected Diseases (DNDi), Latin America

2. Mr James Love, Director, Knowledge Ecology

International, USA

21 November, 2017-Tuesday, 15:30-16:00: Tea Break

21 November, 2017-Tuesday, 16:00-17:30: Wrap up for Parallel

Sessions (1-2)

Time Wrap up for Parallel Sessions (1-2) - Tuesday, 21 November

2017

Room

Tuesday,

16:00-

17:30

(Inviting comments from all)

Chair: Professor Anthony D So, Professor of the Practice and

Director, IDEA (Innovation+Design Enabling Access) Initiative,

Department of International Health, Johns Hopkins Bloomberg

School of Public Health, Baltimore, Maryland, USA

Co-chair: Dr RK Vats, Additional Secretary, Ministry of Health and

Family Welfare, GOI

A

Parallel Sessions 1: Regulatory Pathways For Safe, Quality,

Efficacious And Affordable Medical Products Including In

Emergencies To Achieve SDG Goals

Presentation by Rapporteur

Parallel Sessions 2: Affordability and Fair Pricing of Medical

Products

6


Finalize for report (all Rapporteurs + Facilitators+ transcripts)

7

Wednesday, 22nd November, 2017:Programme

Innovation and Research & Development for Achieving SDGs

22 November 2017- Wednesday, 08:00-09:00: Registration

22 November 2017- Wednesday, 09:00-10:30: Plenary Session 2:

Role of Innovation, Research and Development for Medical

Products

Time Plenary Session 2 - Wednesday, 22 November 2017 Room

Wednesday,

9:00-10:30

Role of Innovation, Research and Development for

Medical Products

Chair: Professor K Vijayraghavan, Secretary, Department of

Biotechnology, GOI; Ms Aradhana Johri, Former Secretary

Department of Pharmaceuticals (DoP), Ministry of Chemicals

and Fertilizers, Secretary of Finance (Disinvestment); Former

Additional Secretary, Ministry of Health & Family Welfare, GOI

Co-chair: Dr Gagandeep Kang, Executive Director,

Translational Health Science and Technology, India

A

Lead Discussants

1. Dr Renu Swarup, Senior Adviser, Department of

Biotechnology (DBT) and Managing Director,

Biotechnology Industry Research Assistance Council

(BIRAC)- Biopharma Mission, India

2. Dr Madhur Gupta, Technical Officer-Pharmaceuticals,

WHO India

3. Dr Surinder Singh, Director, National Institute of

Biologics (NIB), India

Panelists

1. Mr Ed Whiting, Director of Policy and Chief of Staff,

Wellcome Trust UK

8

2. Dr Suman Rijal, Executive Director, Drugs for Neglected

Diseases (DNDi), India

3. Dr Nilima Kshirsagar, National Chair of Clinical

Pharmacology, Indian Council of Medical Research,

India

4. Professor Anthony D So, Professor of the Practice and

Director, IDEA (Innovation+Design Enabling Access)

Initiative, Department of International Health, Johns

Hopkins Bloomberg School of Public Health, Baltimore,

Maryland, USA

22 November 2017- Wednesday, 10:30-10:45: Tea Break

22 November 2017- Wednesday, 10:45-12:30: Plenary Session 3:

Fostering Local Production, Technology Transfer and Market Entry

Barriers for Medical Products

Time Plenary Session 3 - Wednesday, 22 November 2017 Room

Wednesday,

10:45- 12:30

pm

Fostering Local Production, Technology Transfer and

Market Entry Barriers for Medical Products

Chair: Ms Vijaya Srivastava, Additional Secretary and

Financial Adviser, Ministry of Health and Family Welfare, GOI

Co-chair: Mr Sudhansh Pant, Joint Secretary, Department of


Government of India

A

Lead Discussants

1. Dr Jitender Sharma, CEO, Andhra Medtech Zone, and

Advisor, Kalam Institute of Health Technology, Andhra

Pradesh, India

2. Dr Gaby Vercauteren, Senior Advisor, Regulatory

Systems Strengthening Team, Essential Medicines and

Health Products Department, WHO HQ, Geneva

3. Dr Eswara Reddy, Joint Drugs Controller, Central Drug

Standard Control Organization (CDSCO), India

9

Panelists

1. Dr Andrew Rintoul, Scientist, Pricing & Health

Technology Assessment, World Health Organization,

Geneva

2. Dr Diana Tay, Business Development Manager,

Wellcome Trust, UK

3. Ms Deepanwita Chattopadhyay, Chairman & CEO,

Innovation Knowledge Park, India

4. Dr Eur Ing Muthu Singaram, CEO, Healthcare

Technology Innovation Centre, Indian Institute of

Technology Madras, India

22 November 2017- Wednesday, 12:30-13:30: Lunch

22 November 2017- Wednesday, 13:30-15:30: Parallel Session 3:

Infectious Disease Control: What are the Pathways to Technology

Development and Access to Medical Products

Time Parallel Session 3- Wednesday, 22 November 2017 Room

Wednesday,

13:30-15:30

Infectious Disease Control: What are the Pathways to

Technology Development and Access to Medical

Products

Chair: Dr VK Paul, Member, NITI Aayog, GOI

Co-chair: Dr RK Vats, Additional Secretary, Ministry of Health

and Family Welfare, GOI

A

Lead Discussants

1. Dr Stephen B Kennedy, Coordinator for EVD Research,

Incident Management System, Ministry of Health,

Liberia

2. Dr Gagandeep Kang, Executive Director, Translational

Health Science and Technology, India

Panelists

1. Ms Sunita K Sreedharan, Lawyer, SKS Law Associates,

10

India

2. Ms Michelle Childs, Head of Policy and Advocacy,

Drugs for Neglected Diseases (DNDi), Latin America

3. Mr Damiano De Felice, Director of Strategy, Access to

Medicines Foundation, Netherlands

4. Dr Pramod Garg, Professor, Department of Gastro

Enterology, All India Institute of Medical Sciences, India

5. Mr Christoph Spennemann, Legal Officer and Officer-

in-Charge, Intellectual Property Unit, United Nations

Conference on Trade and Development, Geneva

6. Dr Kamal Jayasinghe, Director General/ Chief

Executive Officer, National Medicines Regulatory

Authority, Sri Lanka


Alternative Models of R&D-Industry-Academia Collaborations

Time Parallel Session 4 - Wednesday, 22 November 2017 Room

Wednesday,

13:30-15:30

Alternative Models of R&D-Industry-Academia

Collaborations

Chair: Mr Ed Whiting, Director of Policy and Chief of Staff,

Wellcome Trust UK

Co-chair: Dr Bernard Pecoul, Executive Director, Drugs for

Neglected Diseases (DNDi), Switzerland

B

Lead Discussants

1. Dr Renu Swarup, Department of Biotechnology,

Government of India -‎Biotechnology Industry Research

Assistance, India

2. Dr Madhu Dikshit, Director, Central Drug Research

Institute, India

3. Dr YK Gupta, Professor and Head Department of

Pharmacology, All India Institute of Medical Sciences,

India

11

Panelists

1. Dr Mohga Kamal Yanni, Senior Health and HIV Policy

Adviser, Oxfam GB, UK

2. Ms Siti Aida Abdullah, Deputy Director, National

Pharmaceutical Regulatory Agency, Ministry of

Health, Malaysia

3. Dr Viviana Munoz Tellez, Coordinator, South Centre,

Switzerland

4. Professor Margo A Bagley, Asa Griggs Candler

Professor of Law, Emory University School of Law &

Senior Fellow, Centre for International Governance

Innovation, Atlanta


Achieving SDGs: Use of Information and Communications

Technology (ICT) Initiatives including in Trade Agreements

Time Parallel Session 5- Wednesday, 22 November 2017 Room

Wednesday,

13:30-15:30

Achieving SDGs: Use of Information and

Communications Technology (ICT) Initiatives including in

Trade Agreements

Chair: Dr Sanjay Mehendale, Additional Director General

ICMR, Government of India

Co-chair: Dr GN Singh, Drugs Controller General (India)

C

Lead Discussants

1. Dr VG Somani, Joint Drugs Controller, Central Drugs

Standard Control Organization, India

2. Dr Balram Bhargava, Stanford International Biodesign

Centre, All India Institute of Medical Sciences, India

3. Dr Ananda Sen Gupta, CEO & Founder, Trackmybeat

Health Care Private Limited, India

Panelists

1. Professor Brook K Baker, Professor of Law, North Eastern

12

University, USA

2. Professor Suptendra Nath Sarbadhakari, Project

Director, National Health Portal, India

3. Dr Vinay Goyal, Professor, Department of Neurology,

Neurosciences Centre, All India Institute of Medical

Sciences, India

22 November 2017- Wednesday, 15:30-16:00: Tea Break

22 November 2017- Wednesday, 16:00-17:30: Wrap up for Parallel

Sessions (3-5)

Time Wrap up for Parallel Sessions (3-5)- Wednesday, 22

November 2017

Room

Wednesday,

16:00-17:30


Chair: Dr RK Vats, Additional Secretary, Ministry of Health and

Family Welfare, GOI

Co-chair: Mr Lav Agarwal, Joint Secretary, Ministry of Health

and Family Welfare, GOI

A

Parallel Sessions 3: Infectious Disease Control: What are the

Pathways to Technology Development and Access to

Medical Products


Parallel Sessions 4: Alternative Models of R&D-Industry-

Academia Collaborations


Parallel Sessions 5: Achieving SDGs: Use of Information and

Communications Technology (ICT) Initiatives including in

Trade Agreements



13

Thursday 23rd November, 2017: Programme

Intellectual Property Rights and Trade in the context of Access to

Medical Products for achieving SDGs

23 November 2017-Thursday, 08:00-09:00: Registration

23 November 2017-Thursday, 09:00-10:30: Plenary Session 4: TRIPS,

UN High Level Panel Report and Benefit sharing for access to

medical products

Time Plenary Session 4- Thursday, 23 November 2017 Room

Thursday,

9:00-

10:30

TRIPS, UN High Level Panel Report and Benefit sharing for

access to medical products

Chair: Mr Anadee Nath Misshra, Additional Secretary (OSD),

Ministry of Law and Justice, Government of India

Co-chair: Justice Ravindra Bhat, Judge, High Court of Delhi,

India

A

Lead Discussants

1. Dr Biswajit Dhar, Professor, Jawaharlal Nehru University,

India

2. Professor SK Verma, Secretary General, Indian Society of

International Law, India

Panelists

1. Professor Brook Baker, Professor of Law, Northeastern

University, USA

2. Dr Olasupo Owoeye, Senior Lecturer, Law, RMIT

Graduate School of Business and Law, Australia

3. Dr Carlos Correa, Special Advisor, South Centre,

14

Switzerland

4. Dr Greg Perry, Executive Director, Medicines Patent Pool,

Switzerland

5. Dr Tjandra Yoga Aditama, Senior Advisor, World Health

Organization-South East Asia Regional Office, India

6. Mr Shiba Phurailatpam, Director of the Asia Pacific

Network of People Living with HIV, Thailand

23 November 2017-Thursday, 10:30-10:45: Tea Break

23 November 2017-Thursday, 10:45-12:30: Parallel Session 6:

Patents, Intellectual Property, Price Control and Competition Law

in Access to Medicines

Time Parallel Session 6- Thursday, 23 November 2017 Room

Thursday,

10:45-

12:30

Patents, Intellectual Property, Price Control and

Competition Law in Access to Medicines

Chair: Mr Anadee Nath Misshra, Additional Secretary (OSD),

Ministry of Law and Justice, Government of India

Co-chair: Mr GR Raghavender, Joint Secretary, National Mission

for Justice Delivery and Legal Reforms, Ministry of Law and

Justice, GOI

A

Lead Discussants

1. Dr KS Kardam, Senior Joint Controller Patents and

Designs, Indian Patent Office, India

2. Dr Luca Arnaudo, Senior officer at the Italian Competition

Authority, Rome

3. Dr Peter Beyer, Senior Advisor, Department Of Essential

Medicines and Health Products, World Health

Organization, Geneva

Panelists

1. Professor Stephen Sammut, Senior Advisor ABLE and

Biotechnology Industry Organization, USA

15

2. Mr Christoph Spennemann, Legal Officer and Officer-in-

Charge, Intellectual Property Unit, United Nations

Conference on Trade and Development, Geneva

3. Professor Christoph Rademacher, Associate Professor,

Waseda University, School of Law, Japan

4. Ms Judit Rius Sanjuan, Consultant, United Nations

Development Program, USA

23 November 2017-Thursday, 10:45-12:30: Parallel Session 7: WTO

Trade Agreements influencing Health Products– Context SDGs


Thursday,

10:45-

12:30

WTO Trade Agreements influencing Health Products–

Context SDGs

Chair: Mr Sudhanshu Pandey, Joint Secretary- Trade Policy

Division, Ministry of Commerce and Industry, Government of

India; Mr Sudhansh Pant, Joint Secretary, Department of


Government of India

Co-chair: Dr Sachin Chaturvedi, Director General, Research &

Information System for Developing Countries (RIS), New Delhi,

India

B

Lead Discussants

1. Dr Manisha Shridhar, Regional Advisor, World Health

Organization- South East Asia Regional Office, India

Panelists

1. Dr Gregory Messenger, Lecturer in Law, School of Law

and Social Justice, University of Liverpool, UK

2. Dr Reji K Joseph, Associate Professor, , Institute for Studies

in Industrial Development, India

3. Dr VG Hegde, Professor, Centre for International Legal

Studies, School of International Studies, Jawaharlal Nehru

University, New Delhi

16

23 November 2017-Thursday, 10:45-12:30: Parallel Session 8:

Achieving SDGs: Regional Agreements, Challenges (TRIPS plus

Agreements) and Access to Medical Products


Thursday,

10:45-

12:30

Achieving SDGs: Regional Agreements, Challenges (TRIPS

plus Agreements) and Access to Medical Products

Chair: Mr Rajiv Aggarwal, Joint Secretary, Department of

Industrial Policy and Promotion, Ministry of Commerce and

Industry, GOI

Co-chair: Professor SK Verma, Secretary General, Indian Society

of International Law, India

C

Lead Discussants

1. Professor TC James, Consultant, Research and

Information System for Developing Countries (RIS), and

President, NIPO, India

2. Dr Olasupo Owoeye, Senior Lecturer, Law, RMIT

Graduate School of Business and Law, Australia

Panelists

1. Professor Anthony D So, MD, MPA, Professor of the

Practice and Director, IDEA (Innovation+Design Enabling

Access) Initiative, Department of International Health,

Johns Hopkins Bloomberg School of Public Health,

Baltimore, Maryland, USA

2. Ms Michelle Childs, Head of Policy and Advocacy, Drugs

for Neglected Diseases (DNDi), Latin America

3. Dr Burcu Kilic, Legal Counsel, Public Citizen, USA

4. Ms Kajal Bhardwaj, Consultant, Access to Drugs and

Intellectual Property

5. Professor Rujitha Shenoy, Inter-University for IPR Studies,

India

6. Mr KM Gopakumar, Legal Advisor, Third World Network,

India

17

23 November 2017-Thursday, 12:30-13:30: Lunch

Thursday, 13:30-15:30: Wrap up for Parallel Sessions (6-9)

Time Wrap up for Parallel Sessions (6-8) - Thursday, 23

November 2017

Room

Thursday,

13:30-

15:30


Chair: Mr Sudhanshu Pandey, Joint Secretary- Trade Policy

Division, Ministry of Commerce and Industry, GOI; Mr GR

Raghavender, Joint Secretary, National Mission for Justice

Delivery and Legal Reforms, Ministry of Law and Justice, GOI

Co-chair: Dr Sachin Chaturvedi, Director General, Research &

Information System for Developing Countries (RIS), New Delhi,

India

A

Parallel Sessions 6: Patents, Intellectual Property, Price Control

and Competition Law in Access to Medicines


Parallel Sessions 7: WTO Trade Agreements influencing Health

Products– Context SDGs


Parallel Sessions 8: Achieving SDGs: Regional Agreements,

Challenges (TRIPS plus Agreements) and Access to Medical

Products



3 November 2017-Thursday, 15:30-16:00: Tea Break

23 November 2017- Thursday, 16:00-17:30: Plenary Session 5:

Closing Session

1st world conference on access to medical products and ... wednesday, 22nd november, 2017:programme...

Documents